InterCure Ltd. , together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally.
Intercure stock last closed at $1.52, down 1.3% from the previous day, and has decreased 41.98% in one year. It has overperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 0.17 percentage points. Intercure stock is currently +29.91% from its 52-week low of $1.17, and -59.14% from its 52-week high of $3.72.
As of Apr 29, 2025, there are 45.57M INCR shares outstanding. The market value of INCR is $69.27M. In the past 24 hours, 6516 INCR shares were traded.
You will need a brokerage account in order to access the NASDAQ market and buy INCR stock.
We believe that eToro is the best online stock brokerage. eToro gives you:
Get $10 towards your purchase of stock by creating an account with eToro today. This offer is only for US users.
Open eToro AccountNow that you've picked your brokerage, it's time to fill out some personal details so you can buy INCR stock today.
Now that you have filled out your info on one of the most highly reviewed stock market apps, your next step is to transfer the money for your investment:
Watch the tutorial below for more details depositing money into your new investment account.
Once you have identified the best place to buy Intercure stock, it's very important to analyze their stock before you buy, so you truly comprehend the risk as well as the opportunity.
WallStreetZen was built to help everyday investors perform more accurate fundamental analysis.
You can view all of the due diligence checks on INCR's stock page.
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge INCR's fair value.
Using relative valuations methods:
You can do more valuation research on INCR's stock here.
Last year, INCR revenue was $73.30M. During the past 3 year, INCR's revenue has increased by 94.29% per year. This was faster than the Drug Manufacturers - Specialty & Generic industry average of 7.88%.
You can research INCR's earnings and revenue performance here.
Over the past 12 months, executives and large shareholders at INCR have not bought or sold any shares.
Dig into more about who owns INCR stock here.
No, Intercure doesn't provide an income stream by paying out dividends.
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other traders have to say.
You have two main options:
Click the Open button and eToro will place your order.
If you want additional help with investing in stocks on eToro, watch the helpful video below:
Now that you own some INCR stock, you'll want to keep up with your new investment.
Add INCR to a watchlist to track the latest developments regarding your INCR stock.
To reiterate, here are the 6 steps for buying Intercure stock:
If you are looking for a place to buy stocks, eToro is our recommended option.
Get Started with eToro TodayIf you would like to keep track of your investment in Intercure, create your watchlist below.